← 返回事件
持续讨论商业

After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring

图:MarketWatch

发生了什么

Just days after a capital-markets day left investors wondering what’s next for Novo Nordisk, the Danish drug giant struck a licensing deal worth over $1 billion.

摘要按规则整理自下方来源原文

来源